Bridgebio Pharma shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bridgebio Pharma by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $304k | 275k | 1.11 |
| 2024-03-31 | $39M | 47M | 0.82 |
| 2023-12-31 | $45M | 53M | 0.85 |
| 2023-09-30 | $40M | 53M | 0.76 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas